Immunotherapy for metastatic renal cell carcinoma

BACKGROUND: Since the mid‐2000s, the field of metastatic renal cell carcinoma (mRCC) has experienced a paradigm shift from non‐specific therapy with broad‐acting cytokines to specific regimens, which directly target the cancer, the tumour microenvironment, or both. Current guidelines recommend targe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Unverzagt, Susanne, Moldenhauer, Ines, Nothacker, Monika, Roßmeißl, Dorothea, Hadjinicolaou, Andreas V, Peinemann, Frank, Greco, Francesco, Seliger, Barbara
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2017
Assuntos:
Medicine General & Introductory Medical Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484451/
https://ncbi.nlm.nih.gov/pubmed/28504837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011673.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados